Harvard University has announced its keen interest in a pioneering project developed by students from Uganda’s Makerere University. Spearheaded by the College of Natural Sciences at Makerere, this project focuses on detecting cancer-causing substances in water and the environment, with Harvard’s Innovations Incubator now joining forces to propel it to global significance.
The collaboration between Makerere and Harvard represents a significant milestone in the advancement of biosensor technology. Makerere University’s project has been selected as the sole African representative for Harvard’s Global Nucleate Activation Program. This prestigious four-month online initiative, scheduled to commence on May 21, 2024, aims to transform the innovative project into a global solution for cancer treatment.
Dr. Julius Mulindwa, a Principal Investigator at Makerere’s Department of Biochemistry, underscored the importance of international recognition and support for student-driven initiatives. He highlighted how exposure gained from competitions and collaborations with institutions like Cambridge and Harvard has spurred investment in scientific endeavors, even amid challenges such as the COVID-19 pandemic.
Mr. Michael Okea, a fourth-year Medicine and Surgery student and lead of Makerere’s project team, shared insights into the project’s journey. Their participation in the 2023 International Genetically Engineered Machine Competition in Paris earned them a silver medal. The team’s biosensor technology successfully detected 16 cancer-causing substances in water sources within Kampala’s Kawempe Division.
The upcoming incubator program at Harvard in May 2024 aims to further refine the project, validate its effectiveness, and provide guidance on packaging and marketing strategies. This initiative underscores the commitment of both institutions to leverage innovation for the benefit of global health and cancer prevention.
The students involved in the project are being groomed to present their innovative solution to Chief Executive Officers of established biotechnology companies in the United States. This opportunity not only recognizes their efforts but also provides a platform to showcase African innovation on a global stage.
With Harvard University’s support, Makerere University’s project holds the promise of revolutionizing cancer detection, providing a beacon of hope for millions around the world. As this partnership unfolds, the potential for impactful change in the field of biosensor technology grows ever brighter.
